Feds Bet on Wrong COVID Horse Again as Pfizer’s Own Research Casts Doubt on Pricey Paxlovid

Pfizer Research and Development lab La Jolla, CA

There may be a reason Pfizer chose that curious tagline in the drugmaker’s once-inescapable commercials for its COVID-19 oral antiviral – the subject of a “Saturday Night Live” parody – which cost U.S. taxpayers at least $12 billion before the feds tightened the spigot last fall and Pfizer jacked the price to $1,390 for a five-day course.

The nirmatrelvir-ritonavir combination marketed as Paxlovid does no better against so-called long COVID than a placebo taken with ritonavir, according to a new “original investigation” quietly released Friday in JAMA Internal Medicine, published by the Journal of the American Medical Association.

Read More

Genomics Expert Who Discovered DNA Contamination in mRNA Shots Accuses Regulators of Lying About Cancer Risks

Moderna COVID Vaccine

The scientist who first blew the whistle on the DNA contamination in the COVID mRNA injections last year, said Monday that regulators and fact checkers have been “continually wrong” about his alarming discovery, downplaying its significance and telling flat out lies about the potential dangers.

Last April, microbiologist Kevin McKernan, published a paper establishing that simian virus 40 (SV40), a virus found in monkeys and humans, is present in Pfizer and Moderna’s mRNA COVID-19 injections. The discovery was highly significant because SV40 has been linked to cancer in humans, and since the rollout of the mRNA products, the western world has seen a dramatic increase in cancers, especially in previously healthy working aged people.

Read More

COVID Vaccine ‘Adverse Events of Special Interest’ More Common than Expected: CDC-Funded Study

COVID Vaccine

Rep. Debbie Dingell developed a severe nerve condition from a mandatory swine flu vaccine, which initially made her “scared to death” to get a COVID-19 vaccine, she told a congressional hearing last week. 

The Michigan Democrat might want to reconsider her now-unquestioning enthusiasm for COVID vaccines, including those made through traditional methods, in light of a massive international study of “adverse events of special interest” funded by the Centers for Disease Control and Prevention and set to be published in the peer-reviewed Elsevier journal Vaccine.

Read More

Commentary: Moderna Came Up with a Vaccine Against Vaccine Dissent

Moderna Vaccine

Finances at the vaccine manufacturer Moderna began to fall almost as quickly as they had risen, as most Americans resisted getting yet another COVID booster shot. The pharmaceutical company, whose pioneering mRNA vaccine had turned it from small startup to biotech giant worth more than $100 billion in just a few years, reported a third-quarter loss last year of $3.6 billion, as most Americans refused to get another COVID booster shot.

In a September call aimed at shoring up investors, Moderna’s then-chief commercial officer, Arpa Garay, attributed some of the hesitancy pummeling Moderna’s numbers to uninformed vaccine skeptics. “Despite some misinformation,” Garay said, COVID-19 still drove significant hospitalizations. “It really is a vaccine that’s relevant across all age groups,” she insisted.

Read More